Article

Transcriptomic landscape of Pituitary Adenomas: potential diagnostic and therapeutic targets

2025-09-24

Abstract excerpt

<title>Abstract</title> <p>Objective Pituitary adenomas (PAs) account for 10–15% of intracranial neoplasms. Although generally benign, many PAs, especially non-functional types lack effective medical treatments. Cell membrane proteins are promising targets for diagnosis and therapy due to their accessibility and specificity. This study aimed to identify shared and subtype-specific deregulated membrane proteins ac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5cf19423-efcc-55c9-8323-322eff983179
DOI: 10.21203/rs.3.rs-7604876/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Transcriptomic landscape of Pituitary Adenomas: potential diagnostic and therapeutic targetsDOI 10.21203/rs.3.rs-7604876/v1Read

Transcriptome and methylome analysis reveals three cellular origins of pituitary tumorsSemantic proximity Read

Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysisSemantic proximity Read

Annotation of pituitary neuroendocrine tumors with genome-wide expression analysisSemantic proximity Read

Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomasSemantic proximity Read

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumorsSemantic proximity Read

Proteogenomic Landscape and Clinical Characterization of GH-Producing Pituitary AdenomaSemantic proximity Read

Machine learning to comprehensively reveal signature genes and regulatory mechanisms in pituitary tumorsSemantic proximity Read

Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumorsSemantic proximity Read

Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor CellsSemantic proximity Read

Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumorsSemantic proximity Read

TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomasSemantic proximity Read

Multi-omics analysis Identifies PTTG1 as a prognostic biomarker associated with immunotherapy and chemotherapy resistanceSemantic proximity Read